Efficacy Measure Enhertu (5.4 mg/kg) Total Evaluable (n=261) i T-DM1 (3.6 mg/kg) Total Evaluable (n=263) Landmark 12-month OS (%) (95%...
how does enhertu work
The initial dose should be administered as a 90-minute intravenous infusion. If the prior infusion was well tolerated, subsequent doses...
Enhertu outperformed Roche’s fellow antibody-drug conjugate Kadcyla at staving off tumor progression or death in patients with HER2-positive, metastatic breast...
